Free Trial

Enfusion Q2 2024 Earnings Report

Enfusion logo
$10.75 -0.28 (-2.54%)
(As of 12/18/2024 05:11 PM ET)

Enfusion EPS Results

Actual EPS
$0.02
Consensus EPS
$0.03
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Enfusion Revenue Results

Actual Revenue
$49.46 million
Expected Revenue
$50.27 million
Beat/Miss
Missed by -$810.00 thousand
YoY Revenue Growth
N/A

Enfusion Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry. 

Enfusion Earnings Headlines

Enfusion To Present at Upcoming Investor Events
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
Enfusion To Present at Upcoming Investor Events
Q3 2024 Enfusion Inc Earnings Call
See More Enfusion Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Enfusion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enfusion and other key companies, straight to your email.

About Enfusion

Enfusion (NYSE:ENFN) provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

View Enfusion Profile

More Earnings Resources from MarketBeat

Upcoming Earnings